Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
DOX vs CSGS vs CNXC vs EPAM vs CTSH
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Information Technology Services
Information Technology Services
Information Technology Services
DOX vs CSGS vs CNXC vs EPAM vs CTSH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $7.06B | $2.29B | $1.79B | $5.51B | $24.61B |
| Revenue (TTM) | $4.58B | $1.24B | $9.83B | $5.56B | $21.41B |
| Net Income (TTM) | $572M | $64M | $-1.28B | $387M | $2.23B |
| Gross Margin | 37.6% | 48.3% | 33.3% | 28.5% | 32.1% |
| Operating Margin | 17.7% | 13.9% | 6.2% | 9.9% | 15.7% |
| Forward P/E | 8.7x | 15.9x | 2.2x | 8.2x | 9.1x |
| Total Debt | $826M | $587M | $4.64B | $144M | $1.57B |
| Cash & Equiv. | $325M | $180M | $327M | $1.30B | $1.90B |
DOX vs CSGS vs CNXC vs EPAM vs CTSH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Amdocs Limited (DOX) | 100 | 99.0 | -1.0% |
| CSG Systems Interna… (CSGS) | 100 | 185.3 | +85.3% |
| Concentrix Corporat… (CNXC) | 100 | 31.8 | -68.2% |
| EPAM Systems, Inc. (EPAM) | 100 | 32.4 | -67.6% |
| Cognizant Technolog… (CTSH) | 100 | 66.5 | -33.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DOX vs CSGS vs CNXC vs EPAM vs CTSH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DOX has the current edge in this matchup, primarily because of its strength in income & stability.
- Dividend streak 12 yrs, beta 0.58, yield 3.1%
- 12.5% margin vs CNXC's -13.0%
- 3.1% yield, 12-year raise streak, vs CNXC's 5.6%, (1 stock pays no dividend)
CSGS is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 114.6% 10Y total return vs DOX's 36.5%
- Lower volatility, beta 0.44, current ratio 1.44x
- Beta 0.44, yield 1.6%, current ratio 1.44x
- Beta 0.44 vs CNXC's 1.38
CNXC ranks third and is worth considering specifically for value.
- Lower P/E (2.2x vs 9.1x)
EPAM is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 15.4%, EPS growth -14.3%, 3Y rev CAGR 4.2%
- PEG 0.70 vs CSGS's 9.33
- 15.4% revenue growth vs DOX's -9.4%
CTSH is the clearest fit if your priority is efficiency.
- 10.9% ROA vs CNXC's -10.8%, ROIC 18.7% vs 5.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.4% revenue growth vs DOX's -9.4% | |
| Value | Lower P/E (2.2x vs 9.1x) | |
| Quality / Margins | 12.5% margin vs CNXC's -13.0% | |
| Stability / Safety | Beta 0.44 vs CNXC's 1.38 | |
| Dividends | 3.1% yield, 12-year raise streak, vs CNXC's 5.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +33.5% vs CNXC's -46.7% | |
| Efficiency (ROA) | 10.9% ROA vs CNXC's -10.8%, ROIC 18.7% vs 5.6% |
DOX vs CSGS vs CNXC vs EPAM vs CTSH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DOX vs CSGS vs CNXC vs EPAM vs CTSH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CSGS leads in 2 of 6 categories
DOX leads 1 • CNXC leads 1 • EPAM leads 1 • CTSH leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DOX leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTSH is the larger business by revenue, generating $21.4B annually — 17.3x CSGS's $1.2B. DOX is the more profitable business, keeping 12.5% of every revenue dollar as net income compared to CNXC's -13.0%. On growth, EPAM holds the edge at +7.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.6B | $1.2B | $9.8B | $5.6B | $21.4B |
| EBITDAEarnings before interest/tax | $1.0B | $225M | $773M | $684M | $3.9B |
| Net IncomeAfter-tax profit | $572M | $64M | -$1.3B | $387M | $2.2B |
| Free Cash FlowCash after capex | $755M | $131M | $572M | $544M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +37.6% | +48.3% | +33.3% | +28.5% | +32.1% |
| Operating MarginEBIT ÷ Revenue | +17.7% | +13.9% | +6.2% | +9.9% | +15.7% |
| Net MarginNet income ÷ Revenue | +12.5% | +5.1% | -13.0% | +7.0% | +10.4% |
| FCF MarginFCF ÷ Revenue | +16.5% | +10.6% | +5.8% | +9.8% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.1% | +4.8% | +4.3% | +7.6% | +5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.0% | +45.6% | -14.9% | +18.8% | +3.7% |
Valuation Metrics
CNXC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 11.4x trailing earnings, CTSH trades at a 72% valuation discount to CSGS's 40.6x P/E. Adjusting for growth (PEG ratio), CTSH offers better value at 0.94x vs CSGS's 23.89x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7.1B | $2.3B | $1.8B | $5.5B | $24.6B |
| Enterprise ValueMkt cap + debt − cash | $7.6B | $2.7B | $6.1B | $4.4B | $24.3B |
| Trailing P/EPrice ÷ TTM EPS | 12.90x | 40.60x | -1.25x | 15.53x | 11.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.74x | 15.86x | 2.17x | 8.17x | 9.14x |
| PEG RatioP/E ÷ EPS growth rate | 2.03x | 23.89x | — | 4.18x | 0.94x |
| EV / EBITDAEnterprise value multiple | 7.43x | 7.26x | 4.84x | 6.74x | 5.95x |
| Price / SalesMarket cap ÷ Revenue | 1.56x | 1.87x | 0.18x | 1.01x | 1.17x |
| Price / BookPrice ÷ Book value/share | 2.10x | 8.00x | 0.58x | 1.60x | 1.67x |
| Price / FCFMarket cap ÷ FCF | 10.95x | 16.21x | 3.13x | 8.99x | 9.48x |
Profitability & Efficiency
EPAM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CSGS delivers a 22.0% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-33 for CNXC. EPAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CSGS's 2.07x. On the Piotroski fundamental quality scale (0–9), DOX scores 6/9 vs CNXC's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.5% | +22.0% | -33.2% | +10.7% | +14.8% |
| ROA (TTM)Return on assets | +9.0% | +4.3% | -10.8% | +8.1% | +10.9% |
| ROICReturn on invested capital | +15.6% | +32.5% | +5.6% | +15.5% | +18.7% |
| ROCEReturn on capital employed | +16.8% | +33.7% | +6.6% | +13.3% | +21.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.24x | 2.07x | 1.69x | 0.04x | 0.10x |
| Net DebtTotal debt minus cash | $501M | $407M | $4.3B | -$1.2B | -$326M |
| Cash & Equiv.Liquid assets | $325M | $180M | $327M | $1.3B | $1.9B |
| Total DebtShort + long-term debt | $826M | $587M | $4.6B | $144M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 23.45x | 6.10x | -3.07x | — | 107.78x |
Total Returns (Dividends Reinvested)
CSGS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSGS five years ago would be worth $18,936 today (with dividends reinvested), compared to $1,974 for CNXC. Over the past 12 months, CSGS leads with a +33.5% total return vs CNXC's -46.7%. The 3-year compound annual growth rate (CAGR) favors CSGS at 19.9% vs CNXC's -30.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -18.0% | +5.2% | -36.5% | -47.9% | -35.7% |
| 1-Year ReturnPast 12 months | -24.7% | +33.5% | -46.7% | -34.4% | -31.7% |
| 3-Year ReturnCumulative with dividends | -21.3% | +72.4% | -65.7% | -55.0% | -9.8% |
| 5-Year ReturnCumulative with dividends | -3.5% | +89.4% | -80.3% | -77.3% | -22.9% |
| 10-Year ReturnCumulative with dividends | +36.5% | +114.6% | -61.0% | +48.8% | +0.0% |
| CAGR (3Y)Annualised 3-year return | -7.7% | +19.9% | -30.0% | -23.4% | -3.4% |
Risk & Volatility
CSGS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CSGS is the less volatile stock with a 0.44 beta — it tends to amplify market swings less than CNXC's 1.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSGS currently trades 99.7% from its 52-week high vs CNXC's 41.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 0.44x | 1.38x | 1.21x | 0.75x |
| 52-Week HighHighest price in past year | $95.41 | $80.67 | $62.14 | $222.53 | $87.03 |
| 52-Week LowLowest price in past year | $62.75 | $60.04 | $22.85 | $99.67 | $50.81 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +99.7% | +41.0% | +46.9% | +59.7% |
| RSI (14)Momentum oscillator 0–100 | 41.9 | 56.6 | 36.1 | 22.5 | 23.6 |
| Avg Volume (50D)Average daily shares traded | 980K | 342K | 1.6M | 1.3M | 5.9M |
Analyst Outlook
Evenly matched — DOX and CNXC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DOX as "Buy", CSGS as "Buy", CNXC as "Buy", EPAM as "Buy", CTSH as "Hold". Consensus price targets imply 104.2% upside for CNXC (target: $52) vs 0.4% for CSGS (target: $81). For income investors, CNXC offers the higher dividend yield at 5.59% vs CSGS's 1.65%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $90.00 | $80.70 | $52.00 | $197.00 | $83.33 |
| # AnalystsCovering analysts | 11 | 15 | 9 | 37 | 51 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +1.6% | +5.6% | — | +2.4% |
| Dividend StreakConsecutive years of raises | 12 | 1 | 5 | — | 9 |
| Dividend / ShareAnnual DPS | $2.01 | $1.33 | $1.42 | — | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.8% | +3.6% | +10.5% | 0.0% | +5.6% |
CSGS leads in 2 of 6 categories (Total Returns, Risk & Volatility). DOX leads in 1 (Income & Cash Flow). 1 tied.
DOX vs CSGS vs CNXC vs EPAM vs CTSH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DOX or CSGS or CNXC or EPAM or CTSH a better buy right now?
For growth investors, EPAM Systems, Inc.
(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus -9. 4% for Amdocs Limited (DOX). Cognizant Technology Solutions Corporation (CTSH) offers the better valuation at 11. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Amdocs Limited (DOX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DOX or CSGS or CNXC or EPAM or CTSH?
On trailing P/E, Cognizant Technology Solutions Corporation (CTSH) is the cheapest at 11.
4x versus CSG Systems International, Inc. at 40. 6x. On forward P/E, Concentrix Corporation is actually cheaper at 2. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: EPAM Systems, Inc. wins at 0. 70x versus CSG Systems International, Inc. 's 9. 33x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DOX or CSGS or CNXC or EPAM or CTSH?
Over the past 5 years, CSG Systems International, Inc.
(CSGS) delivered a total return of +89. 4%, compared to -80. 3% for Concentrix Corporation (CNXC). Over 10 years, the gap is even starker: CSGS returned +114. 6% versus CNXC's -61. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DOX or CSGS or CNXC or EPAM or CTSH?
By beta (market sensitivity over 5 years), CSG Systems International, Inc.
(CSGS) is the lower-risk stock at 0. 44β versus Concentrix Corporation's 1. 38β — meaning CNXC is approximately 213% more volatile than CSGS relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 2% for CSG Systems International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DOX or CSGS or CNXC or EPAM or CTSH?
By revenue growth (latest reported year), EPAM Systems, Inc.
(EPAM) is pulling ahead at 15. 4% versus -9. 4% for Amdocs Limited (DOX). On earnings-per-share growth, the picture is similar: Amdocs Limited grew EPS 18. 8% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DOX or CSGS or CNXC or EPAM or CTSH?
Amdocs Limited (DOX) is the more profitable company, earning 12.
5% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 12. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CSGS leads at 24. 5% versus 6. 2% for CNXC. At the gross margin level — before operating expenses — CSGS leads at 47. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DOX or CSGS or CNXC or EPAM or CTSH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, EPAM Systems, Inc. (EPAM) is the more undervalued stock at a PEG of 0. 70x versus CSG Systems International, Inc. 's 9. 33x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Concentrix Corporation (CNXC) trades at 2. 2x forward P/E versus 15. 9x for CSG Systems International, Inc. — 13. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNXC: 104. 2% to $52. 00.
08Which pays a better dividend — DOX or CSGS or CNXC or EPAM or CTSH?
In this comparison, CNXC (5.
6% yield), DOX (3. 1% yield), CTSH (2. 4% yield), CSGS (1. 6% yield) pay a dividend. EPAM does not pay a meaningful dividend and should not be held primarily for income.
09Is DOX or CSGS or CNXC or EPAM or CTSH better for a retirement portfolio?
For long-horizon retirement investors, CSG Systems International, Inc.
(CSGS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 44), 1. 6% yield, +114. 6% 10Y return). Both have compounded well over 10 years (CSGS: +114. 6%, EPAM: +48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DOX and CSGS and CNXC and EPAM and CTSH?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DOX is a small-cap deep-value stock; CSGS is a small-cap quality compounder stock; CNXC is a small-cap income-oriented stock; EPAM is a small-cap high-growth stock; CTSH is a mid-cap deep-value stock. DOX, CSGS, CNXC, CTSH pay a dividend while EPAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.